Compounds that modulate intracellular calcium
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 07. Juli Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
WHITTEN JEFFREY P [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-07-07, Last update posted on www.tib.eu: 2024-03-20, Last updated: 2024-03-29 |
|---|
| Patentnummer: |
US10703722 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA000685283 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA000685283 | ||
| 003 | DE-627 | ||
| 005 | 20240329155921.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA000685283 | ||
| 035 | |a (EPA)US10703722 | ||
| 035 | |a (EPA)54367223 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a WHITTEN JEFFREY P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Compounds that modulate intracellular calcium |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-07-07, Last update posted on www.tib.eu: 2024-03-20, Last updated: 2024-03-29 | ||
| 520 | |a Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a PEI YAZHONG |4 aut | |
| 700 | 0 | |a CAO JIANGUO |4 aut | |
| 700 | 0 | |a WANG ZHIJUN |4 aut | |
| 700 | 0 | |a ROGERS EVAN |4 aut | |
| 700 | 0 | |a DYCK BRIAN |4 aut | |
| 700 | 0 | |a GREY JONATHAN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 07. Juli |
| 773 | 1 | 8 | |g year:2020 |g day:07 |g month:07 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/54367223/publication/US10703722A1?q=US10703722 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2020 |b 07 |c 07 | ||